Immunology and Microbiology
Measles Virus
100%
Measles
81%
Antibody Response
72%
Severe Acute Respiratory Syndrome Coronavirus 2
54%
COVID-19
54%
Syrian Hamster
54%
Macaca
46%
Viral Disease
39%
Rhesus Monkey
31%
Immunoglobulin G Antibody
30%
Virus Infectivity
30%
Cytomegalovirus
27%
Human Immunodeficiency Virus 1
27%
Mouse
27%
Platelet
27%
Salivary Gland
27%
Human Immunodeficiency Virus Infection
27%
Hamster Model
27%
Sex Difference
27%
Immunodeficiency
27%
Mental Stress
27%
Macaca nemestrina
27%
Rebound
27%
Rubella
27%
Measles Antibody
27%
Innate Immune System
21%
Simian Immunodeficiency Virus
21%
Lymphoid Tissue
20%
Immunoglobulin G
16%
Human Immunodeficiency Virus
16%
Bioluminescence
16%
Mucosal Immunity
13%
Infectious Agent
13%
Viral Load
11%
Blood Plasma
11%
Monocyte
10%
Platelet Count
10%
Monospecific Antibody
10%
Neutralization
10%
Thrombocyte Activation
10%
Peripheral Blood Mononuclear Cell
9%
Body Weight
9%
Lymphocytopenia
9%
Virology
9%
Immunology
9%
Alveolar Macrophage
9%
SARS Coronavirus
9%
Lung Weight
9%
Morphology
9%
Neutralizing Antibody
8%
Keyphrases
Respiratory Tract
41%
Measles
32%
Virus
31%
Measles Virus
31%
Rhesus Macaque
27%
Syrian Hamster Model
27%
Cytomegalovirus Replication
27%
Human Immunodeficiency Virus Type 1 (HIV-1)
27%
Animal Research
27%
Salivary Gland
27%
Pandemic Response
27%
Immunoglobulin G Antibodies
27%
COVID-19
27%
Exposure Therapy
27%
Remdesivir
27%
Syrian Hamster
27%
Pre-exposure Prophylaxis (PrEP)
27%
Platelets
27%
Latent Reservoir
27%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
27%
Measles-mumps-rubella Vaccine
27%
Live Attenuated
27%
Immune Amnesia
27%
Pregenomic RNA (pgRNA)
19%
Lung
16%
Inoculation
16%
Infectious Virus
15%
Virus RNA
15%
Clinical Disease
13%
Viral Outgrowth Assay
12%
Macaque
10%
Mucosal Immunity
10%
Murine CMV
10%
Lymphoid Tissue
9%
Late Treatment
9%
Antibody Response
9%
Euthanized
8%
Immunoglobulin G
7%
Antiretroviral Therapy
7%
COVID-19 Pandemic
6%
Current Response
6%
Cytomegalovirus Infection
6%
Platelet Depletion
6%
Therapy Development
6%
1918 Spanish Flu
6%
Scientific Community
6%
Zika Outbreak
6%
Major Infectious Diseases
6%
Innate Immune Parameters
6%
SARS-CoV-2 Vaccine
6%
Medicine and Dentistry
COVID-19
54%
Severe Acute Respiratory Syndrome Coronavirus 2
54%
Infection
41%
Salivary Gland
27%
Sex Difference
27%
Antibody Response
27%
Platelet
27%
Cytomegalovirus
27%
Virus Infectivity
21%
Virus RNA
18%
Disease
15%
Body Weight
9%
Histopathology
9%
Clinical Pathology
9%
Hyperplasia
9%
SARS Coronavirus
9%
Morphology
9%
Alveolar Macrophage
9%
Clinical Immunology
9%
Necrosis
9%
Image Analysis
9%
Diethylstilbestrol
6%
Virus Antibody
6%
Pulmonary Pathology
6%